Following the announcement today that the Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) have lifted the pause on the administration of the Johnson & Johnson vaccine, the Iowa Department of Public Health (IDPH) recommends that any vaccine provider in the state who has available Johnson & Johnson vaccine resume administration, effective immediately. 

The Iowa Department of Public Health (IDPH) has confirmed one case of the COVID-19 variant, SARS-CoV-2 P.1  in Iowa. This variant is also referred to as the Brazilian variant. We are still learning about the characteristics of this strain including any potential impact on vaccine effectiveness.

After an announcement this morning from the Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA), the Iowa Department of Public Health (IDPH) is recommending that all Johnson & Johnson COVID-19 vaccine administration in the state should halt until further guidance is issued. IDPH has communicated this guidance to local health officials and vaccine providers throughout the state.

With the announcement from the Centers for Disease Control (CDC) this morning, the Iowa Department of Public Health (IDPH) has advised that all Iowa vaccine providers pause administration of the Johnson & Johnson COVID-19 vaccine until more details are confirmed.

The Iowa Department of Public Health (IDPH) along with Iowa State University Extension and Outreach and University of Iowa announce their collaboration to host information sessions about the COVID-19 vaccine later this month. The sessions will provide a virtual forum for Iowans to learn about the safety and efficacy of COVID-19 vaccines and have an opportunity to ask questions of medical experts.